Société Nuvo Pharmaceuticals Inc Toronto S.E.
Actions
CA67092F1045
Produits pharmaceutiques
Métier
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Jesse Ledger
CEO | Chief Executive Officer | - | 06/04/16 |
Director of Finance/CFO | - | 01/01/12 | |
Bernard Chiasson
COO | Chief Operating Officer | - | - |
Wade Hull
CTO | Chief Tech/Sci/R&D Officer | - | - |
John London
BRD | Director/Board Member | - | - |
Corporate Officer/Principal | - | 01/01/19 | |
Cally Lunetta
PRN | Corporate Officer/Principal | - | - |
Katina Loucaides
LAW | General Counsel | - | 01/01/08 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Rob Harris
CHM | Chairman | 69 | 05/04/17 |
Director/Board Member | - | 21/09/04 | |
John London
BRD | Director/Board Member | - | - |
Mary Ritchie
BRD | Director/Board Member | 67 | 17/05/21 |
Anthony Y. Snow
BRD | Director/Board Member | 49 | 12/08/22 |
Director/Board Member | 68 | 16/05/22 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 11 388 000 | 10 851 712 ( 95,29 %) | 0 | 95,29 % |
Coordonnées société
Nuvo Pharmaceuticals, Inc.
6733 Mississauga Road Suite 800
L5N 6J5, Mississauga
+
http://www.miravohealthcare.comSecteur
Varia. 1 janv. | Capi. | |
---|---|---|
+38,51% | 727 Md | |
+33,05% | 599 Md | |
-6,23% | 354 Md | |
+18,78% | 328 Md | |
+1,35% | 277 Md | |
+16,00% | 243 Md | |
+8,09% | 205 Md | |
-5,77% | 203 Md | |
+6,19% | 164 Md |